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The neural crest is a transient structure of vertebrate embryos that initially generates neural crest stem cells
(NCSCs) which then migrate throughout the body to produce a diverse array of mature tissue types. Due to
the rarity of adult NCSCs as well as ethical and technical issues surrounding isolation of early embryonic
tissues, biologic studies of human NCSCs are extremely challenging. Thus, much of what is known about
human neural crest development has been inferred from model organisms. In this study, we report that
functional NCSCs can be rapidly generated and isolated from in vitro—differentiated human embryonic stem
cells (hESCs). Using the stromal-derived inducing activity (SDIA) of PA6 fibroblast co-culture we have
induced hESCs to differentiate into neural crest. Within 1 week, migrating cells that express the early neural
crest markers p75 and HNK1 as well as numerous other genes associated with neural crest induction such as
SNAIL, SLUG, and SOX10 are detectable. Fluorescence-activated cell sorting (FACS)-based isolation of the
p75-positive population enriches for cells with genetic, phenotypic, and functional characteristics of NCSCs.
These p75-enriched cells readily form neurospheres in suspension culture, self-renew to form secondary
spheres, and give rise under differentiation conditions to multiple neural crest lineages including periph-
eral nerves, glial, and myofibroblastic cells. Importantly, these cells differentiate into neural crest deriva-
tives when transplanted into developing chick embryos in vivo. Thus, this SDIA protocol can be used to
successfully and efficiently isolate early human NCSCs from hESCs in vitro. This renewable source of
NCSCs provides an invaluable source of cells for studies of both normal and disordered human neural crest
development.
Introduction
The neural crest is a transient structure that originatesfrom the dorsal neural tube at the early stages of verte-
brate embryonic development. It gives rise to a vast array of
histologically and geographically diverse cell types includ-
ing, among others, skeletal cells, myofibroblasts, melano-
cytes, and nearly all the cells of the peripheral nervous system
including sympathetic and parasympathetic ganglia, the ad-
renal medulla, autonomic and sensory neurons, and sup-
porting glial cells (i.e., Schwann and satellite) (reviewed in
ref. 1). Given the diversity of its progeny, it is not surprising
that disruption of the neural crest adversely affects human
development and several complex human disorders such as
DiGeorge, Waardenburg and Apert syndromes, neurofibro-
matosis, and Hirschsprung’s disease arise because of aberra-
tions in neural crest development [2,3]. In addition, several
aggressive malignancies including malignant melanoma,
neuroblastoma, and peripheral primitive neuroectodermal
tumors—also known as Ewing sarcoma family tumors—have
been proposed to arise because of genetic mutations in neural
crest–derived cells [2,4–7]. Thus, elucidation of human neural
crest development and the mechanisms by which it is disrupted
in human disease has the potential to profoundly impact our
understanding of disease pathogenesis and, ultimately, afford
opportunities for novel therapeutic interventions.
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To date, knowledge of human neural crest development
has largely been acquired from studies of model organisms
that have defined the genetic and phenotypic characteristics
of neural crest cells at various developmental stages [8].
Through a complex series of tightly regulated molecular
signals, ectodermal cells are first induced to create neural
crest stem cells (NCSCs). Multipotent NCSCs then respond
to differentiation and migration signals and undergo pro-
gressive fate restrictions, giving rise to progenitor cells
(NCPCs) with varying degrees of self-renewal and differ-
entiation potential that are determined by both cell autono-
mous as well as environmental factors (reviewed in ref. [1]).
Induction and differentiation of embryonic neural crest
occurs very early, within only a few weeks of fertilization
[9,10]. Thus, the feasibility of acquiring primary human
neural crest cells from embryonic tissue is severely chal-
lenged by both ethical and technical issues—in fact, neural
crest induction and migration is underway long before most
women even realize that they are pregnant. Although
NCSCs have been isolated from some human adult tissues,
they are exceedingly rare and do not possess the same self-
renewal and pluripotency of early embryonic NCSCs
[1,11,12]. Therefore, to fully advance in vitro studies of
human neural crest development alternate renewable sour-
ces of precursor cells will be required.
In recent years, pluripotent embryonic stem cells have
been shown to be an invaluable source of cells for studies of
developmental biology and regenerative medicine. Em-
bryonic stem cells can be differentiated into cell types from
all three germ layers (endo-, meso-, and ectoderm) and
differentiation along specific lineages can be directed by
altering growth conditions in defined media [13]. Im-
portantly, culture of murine, primate, and human embryonic
stem cells (hESCs) on PA6 murine stromal fibroblasts can
be used to selectively induce terminal differentiation of
neural crest derivatives as a result of so-called stromal-
derived inducing activity (SDIA) of the PA6 feeder layer
[14,15]. In this study, we report that SDIA-treated hESC
transition through a neural crest precursor stage on the path to
terminal differentiation and that isolation of p75-positive cells
after 1 week successfully enriches for multipotent cells with
genetic, phenotypic, and functional characteristics of NCSCs.
This p75-enriched cell population forms neurospheres in
suspension culture and gives rise to peripheral nerves, glial
and myofibroblastic cells under differentiation conditions.
Thus, hESCs represent a renewable source of NCSCs that can
be readily and rapidly accessed for studies of both normal and
disordered human neural crest development.
Materials and Methods
Cell culture
Undifferentiated hESCs H9 (WA-09) and H1 (WA-01)
were cultured as described previously [16] on irradiated
mouse embryo fibroblast (MEF) feeder layers in medium
consisting of a 1:1 mixture of DMEM and nutrient mixture F-
12 supplemented with 20% knockout serum replacement, 1%
nonessential amino acids stock, 1 mM l-glutamine, 4 ng/mL
basic fibroblast growth factor (bFGF) (all from Invitrogen,
Carlsbad, CA), and 0.1 mM -mercaptoethanol (Sigma Che-
mical Corp., St. Louis, MO). All hESC studies were per-
formed with the assurance of the CHLA Stem Cell Research
Oversight Committee. The cells were passaged by semi-
weekly splits of 1:3 and replated on fresh irradiated MEF
feeder layers to maintain an undifferentiated state. Human
ESCs were monitored weekly by fluorescence-activated cell
sorting (FACS) analysis and only cultures with >90% SSEA-
4+ (R&D Systems Inc., Minneapolis, MN) and <1% SSEA-
1+ (R&D, Minneapolis, MN) cells were used. The mouse
stromal PA6 cell line (Riken BSI Research, Japan), was
cultured on gelatin-coated dishes in 90% a-MEM and 10%
fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA).
Neural crest differentiation of hESCs was induced as de-
scribed [15] with some modification. Briefly, hESC colonies
were treated with collagenase (Invitrogen, Carlsbad, CA),
mechanically sectioned into clumps and transferred into PA6-
coated dishes at densities of up to 1,000 colonies per 3-cm
dish. Media was then changed to induction medium con-
taining 90% BHK-21 medium/Glasgow modified Eagle’s
medium (MEM), 10% knockout serum replacement, 2 mM
glutamine, 1 mM pyruvate, 0.1 mM nonessential amino acid
solution, and 0.1 mM b-mercaptoethanol. On day 6, the me-
dia was changed to induction medium with 1X N2 supple-
ment (Invitrogen) and replaced every 2 days thereafter.
FACS analysis and purification
Human ESC colonies were dissociated by incubating them
for 5 min at 37C in Accumax (Chemicon, Temecula, CA).
Cells were gently triturated and filtered through a 30mm cell
strainer to obtain a single-cell suspension. The dissociated
hESCs were then blocked with anti-human Fc-receptor (Mil-
tenyi Biotec, Bergisch Gladbach, Germany) in staining me-
dium containing L15 medium with 10 mM HEPES and 1 mg/
mL bovine serum albumin (BSA). Following Fc blocking,
cells were incubated with the phycoerythrin (PE)-conjugated
anti-p75 (Miltenyi Biotec) for 15 min in the dark at 4C. For
HNK-1 and p75 double staining, the cells were stained with
HNK-1 (Abcam, Cambridge, MA) first, followed by anti-
mouse IgG FITC (Jackson ImmunoResearch Laboratories,
West Grove, PA), and then the conjugated antip75-PE. Cells
were washed with staining media before analysis using a
FACS Calibur (BD Biosciences, San Jose, CA). Cell isolation
was conducted on a FACS Vantage or FACS Aria (BD
Biosciences). Compensation for FITC and PE was performed
using compensation beads (BD Pharmingen, San Jose, CA).
Analysis was done using the Flow-Jo program (Tree Star,
Ashland, OR). Positive and negative gates were determined
using IgG stained and unstained controls.
Limiting dilution analysis
Limiting dilution analysis was performed as described [17].
Cells were plated in either 96-microwell or six-well ultralow
attachment plates (Costar, Corning, Lowell, MA) in media
consisting of DMEM-F12 (1:1), 7.5% chick embryo extract
(US Biological, Swampscott, MA), N2, B27, 20 ng/mL bFGF,
20 ng/mL EGF, 20nM IGF-1, and 0.1 mM b-mercaptoethanol.
For microwell plates, cell numbers were adjusted to 5,000
cells/mL from which serial dilutions were prepared. Final
cell dilutions ranged from 1,000 cells per well to 1 cell per
well in 200mL aliquots. After 7 days the fraction of wells
not containing spheres was determined. The number of cells
required to form one sphere, which reflected the proportion
of stem cells in the entire population, was then determined
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from the point at which the line crossed 0.37 level. That is,
F0 = e-x, where F0 is the fraction of wells without spheres
and x is the mean number of cells per well. Based upon a
Poisson distribution of cells, F0 = 0.37 corresponds to the
dilution at which there is one stem cell per well.
In other experiments, cells were re-suspended and plated
onto six-well ultra-low-attachment plates at serial dilutions
(5–100 · 103 cells/well). The number of spheres was coun-
ted after 1 week and the data presented are mean – standard
deviations (SD) of three independent experiments.
Subcloning and differentiation assays
For subcloning p75+ and p75- primary spheres were cul-
tured in low attachment plates for 1 week and then single
colonies were handpicked and dissociated with Accumax.
The dissociated cells were immediately transferred into cen-
trifuge tubes containing L15 medium with 0.2% BSA and
10 mM HEPES, triturated, counted by hemocytometer, and
spun down at 1,000 rpm for 4 min at 4C. The re-suspended
single cells were then inoculated in low attachment plates at
clonal densities (10–30 cells/cm2). After 7–10 days, each well
was scored for the number of secondary spheres.
To assess differentiation potential, single p75+ or p75-
spheres were handpicked as above and directly plated on
four-well or eight-well chamber slides pre-coated with
10 mg/mL Poly-d-lysine and 150 mg/mL fibronectin. The
cells were switched to differentiation medium containing
DMEM/F12 (1:1) supplemented with N2, B27, and 5% FBS
for another 2 weeks before immunocytochemical charac-
terization of colonies.
Reverse transcription-polymerase chain reaction
Total RNA was extracted from sorted and unsorted cells
using the RNeasy kit and DNAse I treatment (Qiagen, Va-
lencia, CA). RNA (500 ng) was reverse transcribed using
iScript Reverse Transcriptase kit (Bio-Rad, Hercules, CA)
in a 20-mL reaction and 2 mL of reverse-transcription prod-
uct was amplified by polymerase chain reaction (PCR) using
standard protocols. Primer sequences, product length and
annealing temperatures are provided (Supplementary Table
1; Supplementary materials are available online at http://
www.liebertpub.com/scd). Primers were chosen for human
specificity wherever possible and PA6 only and no-RT con-
trols were included in all experiments.
Immunocytochemistry
Expression of NCSC markers, neuronal markers, and
neural crest lineage markers was examined by immunocy-
tochemistry. For glial fibrillary acidic protein (GFAP)
staining, cultures were fixed with a solution of 95% ethanol
and 5% glacial acetic acid at -20C for 20 min. For other
antibodies the cells were fixed with 4% paraformaldehyde
and permeabilized with 0.1% Triton X-100. After a rinsing
in phosphate-buffered saline (PBS), the slides were incu-
bated for 1 h in blocking solution containing 1% bovine
serum albumin and 5% donkey serum in PBS. The slides
were then incubated with the primary antibodies for 1 h at
37C or overnight at 4C. The following antibodies were
used at the indicated dilutions: b-III-tubulin/Tuj1 (1:500;
CRP Inc., Berkley, CA), peripherin (1:500; Chemicon In-
ternational Inc., Billerica, MA), Brn3a (1:100; Chemicon),
TH (1:100; Santa Cruz Biotech, Santa Cruz, CA), NCAM
(1:200; Chemicon), p75 (1: 200; Upstate, Lake Placid, NY),
AP2 (1:100; Santa Cruz Biotech), HNK-1 (1:100; Abcam,
Cambridge, MA), SMA (1:400; Sigma, Saint Louis, MO),
GFAP (1:100; Chemicon). Triple-labeling experiments were
performed by simultaneously incubating samples in ap-
propriate combinations of primary antibodies followed by
non-cross-reactive secondary antibodies (Alexa fluorophore-
conjugated secondary antibodies, 1:1,000; Molecular Probes-
Invitrogen, Eugene, OR) or cy-conjugated secondary antibodies
(1:500; Jackson ImmunoResearch Laboratories Inc., West
Grove, PA). In some samples, nuclei were counterstained
with 4¢, 6-diamidino-2-phenylindole (DAPI). The specificity
of the light microscopic immunocytochemical procedures
was validated by omitting the primary antibodies or by
replacing them with nonimmune serum. Stained slides were
viewed with a Leica DM RXA Upright Fluorescence
Microscope and photographed using a SKY camera on
the system (Applied Spectral Imaging, Inc., Carlsbad, CA)
and no features were removed or added digitally. For
quantitative analysis, differentiated colonies were counted
at different time points as indicated. At least three separate
experiments were performed for quantification purposes.
In vivo transplantation
Fertilized chicken eggs were obtained from AA En-
terprises (AA Enterprises, Ramona, CA) and incubated on
their sides at 38C in humidified incubators (Lyon Electric
Co., Chula Vista, CA). The FACS-isolated p75+ cells were
transduced with a green fluorescent protein (GFP) lentiviral
vector (pCCL-MND-X-PGK-EGFP) and transduction effi-
ciency was *90%. Three to four days after transduction,
EGFP-labeled p75+ cells were transplanted into the area
adjacent to the midbrain of H&H stage 10–12 chick em-
bryos as described [18]. Eggs were incubated for 3 days
after transplantation and the embryos were cryoprotected,
embedded in gelatin, and cryosectioned at 10 mm. The
cryostat sections of chick embryos were then stained with
the primary antibodies at the following concentrations: GFP
(Abcam, Cambridge, MA; 1:500); SMA (Sigma, Saint
Louis, MO; 1:400); Tuj1 (CRP Inc., Cumberland, VA;
1:500); HuC/HuD (Molecular Probes, Eugene, OR; 1:250).
Statistical analysis
Values are reported as means –SD if not indicated oth-
erwise. Paired t test was used for comparing the sphere
formation, subcloning efficiency and clonogenicity of p75+
and p75- cells.
Results
PA6 fibroblast co-culture induces peripheral
neuronal differentiation from hESCs
Neural differentiation of undifferentiated SSEA4+/SSEA1-
hESCs (H1 and H9 lines; Supplementary Fig. 1) was initiated
by culturing on a feeder layer of PA6 stromal cells. By 7 days
of culture on PA6 cells, most hESC colonies had generated an
outgrowth of elongated cells (Fig. 1A, day 7). After 3 weeks
of differentiation, cells that migrated out of the colonies
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formed a monolayer and displayed morphology characteristic
of neurons, with extensive development of fine processes.
Prominent fiber bundles formed by processes emanating from
the colonies were frequently observed (Fig. 1A, day 21).
Colonies positive for the early neural marker TuJ1 first ap-
peared between day 5 and 7 (Fig. 1B, day 7), and the pro-
portion of positive colonies increased during the following
weeks of differentiation. Three weeks after seeding hESCs on
PA6 cells, massive neuronal differentiation with extensive
networks of stained axons was observed using immunocyto-
chemisty (Fig. 1B, day 21). By 4 weeks of differentiation,
>90% of the colonies were Tuj1+ (data not shown).
Next, to ascertain whether peripheral nervous system
neurons are present in SDIA-induced cultures, we co-
immunostained Tuj1 with peripherin, a class III intermediate
neurofilament subunit expressed by peripheral sensory and
autonomic neurons [19]. After 4 weeks of SDIA treatment,
*30% of the colonies contained Tuj1+/peripherin+ peripheral
neurons (Fig. 1C). In addition, cells that co-expressed both
peripherin and the transcription factor Brn3a, a combination of
FIG. 1. Induction of peripheral neu-
rons from human embryonic stem cells
(hESCs) by the stromal cell line PA6.
For neural induction, H1 or H9 cells
were plated at 5–10· 102/cm2 on a
confluent layer of PA6 cells in six-well
plates or chamber slides in induction
medium as described in Materials and
Methods. (A) Phase-contrast photo-
graphs of neural differentiation of H9
induced by PA6 over 3 weeks (Scale
bar = 200 mm). (B) Expression of the
general neuronal marker Tuj1 by H9
colonies on PA6 for 7, 14, or 21 days
(Scale bar = 50 mm). (C–E) Immuno-
staining of H9 colonies after 3 weeks of
culture on PA6 (Scale bars = 50 mm).
(C) Co-expression of peripherin, an in-
termediate filament found in peripheral
axons (red) and Tuj1 (green). (D) Co-
expression of peripherin (red) and the
transcription factor Brn3a (green) found
primarily in peripheral sensory (PS)
neurons. (E) Co-expression of periph-
erin (red) and tyrosine hydroxylase (TH,
green) expressed in putative sympa-
thetic neurons. (F) Quantification of H9
colonies containing Brn3a, TH, and/or
peripherin-immunoreactive cells after 4
weeks of culture on PA6. Results are the
average of three experiments and error
bars = SD.
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markers that is characteristic of peripheral sensory (PS) gan-
glion neurons [20], were apparent in 3-week co-cultures (Fig.
1D). Cells that co-expressed tyrosine hydroxylase (TH) and
peripherin, a combination characteristic of sympathetic gan-
glion (SG) neurons, were also detected (Fig. 1E). Quantitative
analysis of the cultures revealed that by 4 weeks of co-culture,
approximately one quarter of the colonies contained putative
PS neurons while SG neurons were detected in only 18% of
colonies (Fig. 1F). However, the number of peripherin+/
Brn3a+ cells within each colony was widely variable and very
few TH+/peripherin+ double-positive cells were observed in
most of the colonies (Fig. 1E). The low yield of SG neurons
relative to PS neurons may be due to an increased requirement
of bone morphogenic proteins (BMPs) for catecholaminergic
compared with differentiation [14]. Further study with addi-
tion of BMPs to the induction media will help to resolve if SG
differentiation is enhanced under these conditions.
In summary, SDIA co-culture of the hESC cell lines H1
and H9 reliably induces terminal differentiation to periph-
eral neurons within 3–4 weeks. These data are consistent
with earlier studies [15] in which SDIA was used to suc-
cessfully induce terminal neural crest differentiation from
HES-1 and HUES 7 cell lines. Together these studies show
that this rapid and straightforward approach to neural crest
differentiation is broadly applicable to multiple different
hESC cell lines. In our hands, roughly one third of SDIA-
differentiated colonies contain cells that are positive for
peripherin and 18 and 25% of colonies demonstrate differ-
entiation to SG and PS neurons, respectively—although the
number of positive cells within each colony is highly vari-
able. Thus, although feasible, the efficiency and reproduc-
ibility of terminal neural crest differentiation under
nonenriched SDIA conditions is suboptimal for focused
study of human neural crest development.
Generation of putative NCSCs from hESCs
In vivo, all neural crest structures, including peripheral
neurons, develop from populations of NCSCs that initiate in
the developing neuroepithelium and then migrate throughout
the body (reviewed in ref. 1). We therefore reasoned that the
terminally differentiated neurons in our hESC cultures must
have transitioned through a NCSC phase on their transition to
PS and SG nerves. Further, we hypothesized that isolation of
these cells from the cultures would enable enrichment and
improvement of directed neural crest differentiation of hESCs
in vitro. To identify populations of putative NCSCs within
our differentiating hESC cultures we first assayed expression
of NCSC markers by both immunostaining and reverse
transcription (RT)-PCR. Because there is no single gene, or
even combination of two genes, whose expression unequiv-
ocally marks these important cells, we examined our cultures
for the temporal expression of several different molecules
used as early neural crest markers in several species.
By 1 week of co-culture, expression of low-affinity neu-
rotrophin receptor p75, which is highly expressed in migrat-
ing NCSCs [21,22], could be observed in cell clusters and
these were predominantly localized at the periphery of hESC
colonies (Fig. 2A). In addition, consistent with a migratory
phenotype, many of these cells were also identified as
FIG. 2. Induction of putative neural
crest stem cells (NCSCs) from human
embryonic stem cells (hESCs). (A–C)
Immunostaining of H9 colonies after 1
week of culture on PA6. (Scale bars =
50mm). (A) A colony of H9 hESCs
double stained for p75 (red) and Tuj1
(green). Note that the expression of p75
is outside or at the edge of the hESC
colony (asterisk). (B) A colony of H9
hESCs double stained with p75 (red)
and HNK1 (green). (C) A colony of H9
double stained for NCAM (red) and AP-
2 (green), indicative of early migrating
neural crest cells. (D) Quantification of
H9 colonies expressing p75 and /or
HNK1 after 1 week of culture on PA6.
Results are the average of three exper-
iments and error bars = SD.
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individual cells at sites distant from p75+ colonies (Fig. 2A).
The HNK-1 carbohydrate epitope is a residue on various
glycoproteins and glycolipids, and is recognized by mono-
clonal antibody HNK-1. The HNK-1 epitope has been used as
a general marker for neural crest cells in the avian embryo
[23] and in human NCSCs [21]. Therefore, we co-
immunostained cells for both HNK1 and p75. As shown in
Fig. 2B, of the majority of p75+ cells also expressed HNK1
providing further evidence to support their identity as
NCSCs. Quantitative analysis revealed that by 1 week of co-
culture, 55.3– 10.6% of the hESC colonies contained p75+
cells and the vast majority of these colonies were also posi-
tive for HNK1 with virtually complete overlap between
HNK1+ and p75+ cells (Fig. 2D). In addition, we used co-
expression of the transcription factor AP2a and the cell-
surface molecule NCAM as an indicator of neural crest dif-
ferentiation [14,15]. Consistent with p75/HNK1 staining, af-
ter 1 week of co-culture, almost half of the hESC colonies
contained AP2+/NCAM+ cells and the majority of these
double-positive cells were localized at the edge of the colo-
nies (Fig. 2C).
Next, we used RT-PCR to examine the expression of early
neural crest markers in PA6 cells, undifferentiated hESCs and
hESCs over the course of SDIA exposure (Fig. 3A). Semi-
quantitative evaluation of the expression of many of these
genes showed a temporal pattern with induction at 1 week
followed by downregulation by 3 weeks, consistent with the
putative transient appearance of NCSCs in SDIA-
differentiating hESCs. For example, expression of the early
neural crest cell markers SNAIL and SLUG was first detected
at day three, peaked at *1 week, and dramatically decreased
by 3 weeks. Other neural crest development—associated
genes that were also induced by 1 week and diminished by 3
weeks include SOX9, SOX10, and TRKC. However, in
keeping with their known expression in other more differ-
entiated cell types, a few genes that are highly but not spe-
cifically expressed by NCSCs showed the expected induction
at week 1 but little or no subsequent downregulation. The p75
gene, e.g., which is expressed both in migrating neural crest
cells and many postmitotic neurons in dorsal root ganglia
[24], was expressed by both 1 week and 3 week co-cultures.
In addition, the continued expression of MSX1 at 3 weeks
may be explained by its expression in nonneural ectoderm
and mesoderm derivatives in addition to neural crest cells
[25]. Finally, PAX3 is normally expressed in the dorsal neural
tube, the region from which neural crest cells emerge [26] but
it is also detected in the somites and in mature Schwann cells
of murine embryos after E8.5 [27].
Therefore, immunostaining and RT-PCR assays support
the temporal induction of putative NCSCs/NCPCs from
hESCs after 1 week of SDIA treatment. Together, these
findings infer that neural crest precursors capable of dif-
ferentiating into peripheral neurons including PS and SG
neurons emerge from SDIA-induced hESCs very rapidly
upon PA6 co-culture.
Isolation and molecular characterization
of hESC-derived NCSCs
To further characterize the putative NCSCs induced from
hESCs, we used FACS to isolate these target cells from the
bulk cultures. Among the various cell-surface proteins known
to be expressed by the neural crest, p75 has been widely used
to characterize and isolate NCSCs [21,22,28]. Thus, we used
FACS analysis to evaluate the emergence of p75+ cells in our
differentiating hESC cultures. As shown (Fig. 3B), p75+ cells
appeared as early as day two of the culture and continued to
increase in number until day 8. Together with the afore-
mentioned RT-PCR data (Fig. 3A), these findings suggested
to us that the emerging NCSC population peaks at day 7–8
of SDIA induction. In addition, similar temporal analysis of
HNK1 expression by FACS showed that most hESC-derived
FIG. 3. Expression of neural crest stem cell (NCSC) markers in PA6-induced human embryonic stem cell (hESC) cultures.
(A) Reverse transcription-polymerase chain reaction analysis (RT-PCR) of neural crest–associated genes demonstrates tem-
poral induction of these genes over the first 6–7 days. In contrast, PA6 cells and undifferentiated H9 cells do not express these
neural crest markers. (B) Analysis of H9-derived p75+ cells by fluorescence-activated cell sorting (FACS) analysis. Cells were
incubated with FcR blocking reagent and the phycoerythrin (PE)-conjugated anti-p75 for 10 min in the dark at 4C. Cells were
run through a FACS can flow cytometer with standard equipment. A minimum of 10,000 events was collected and acquired in
list mode using the CellQuest software. The dot plots are representative of three independent experiments. P75+ cells appeared
as early as Day 2 of the culture period, and the level of p75 increased dramatically from Day 5 to 8.
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p75+ cells also express HNK1 (data not shown). This is
consistent with our immunocytologic findings and support-
ive of their identification as early NCSCs (Fig. 2).
Next, we proceeded to test whether these p75+ cells
demonstrate genetic and phenotypic characteristics of
human NCSCs. First, we sorted p75+ and p75- cells by
FACS and evaluated the expression of neural crest
marker genes by RT-PCR. As shown in Fig. 4A, the p75+
fraction transcripts were highly enriched for NCSCs ( p75,
SOX10, HNK1, and ERBB3) or key neural crest devel-
opment markers (SLUG, TRKC, PAX3, and POU4F1). In
contrast, markers of central nervous system (CNS) pre-
cursors including WNT5B, FGF8, and FGF17 [21] were
more highly expressed in the p75- population suggesting
that FACS sorting of p75+ cells differentially isolates
NCSCs from CNS stem cells as well as other p75- cell
populations. Gene expression data was confirmed by
immunocytochemistry which showed that markers of
neural crest identity were limited to p75+ cell fractions
(Fig. 4B).
In summary, FACS analysis of differentiating hESCs
demonstrates peak emergence of p75+/HNK1+ cells 1 week
after SDIA induction. Sorting based on p75 expression en-
riches for cells that possess both genetic and phenotypic
characteristics of NCSCs and separates putative neural crest
precursors from CNS precursors.
Characterization and multilineage differentiation of
hESC-derived NCSCs
Having established that p75+ cells express genetic and
phenotypic features of NCSCs we next sought to evaluate
FIG. 4. Molecular characterization and sphere formation analysis of neural crest stem cells (NCSCs). (A) Different gene
expression profiles are displayed by p75+ and p75- populations as assessed by RT-PCR with p75+ cells expressing markers
of putative NCSCs and p75- cells expressing higher levels of CNS stem cell genes (see text). (B) Immunocytochemistry
analysis of FACS-purified p75+ and p75- cells identifies markers of neural crest identity in only the p75+ fraction (Scale
bar = 100mm). (C) Immunostaining of p75+ and p75- spheres generated after 1 week in neurosphere induction media in
anchorage-independent conditions. While both spheres contain cells that express the stem-cell marker nestin, only FACS-
purified p75+ spheres are positive for neural crest stem cell markers HNK1 and p75. (D) Limiting dilution analysis of p75+
and p75- cells. Cells were inoculated into microwell plates at concentrations ranging from 1,000 cells/well to 1 cell/well and
maintained in vitro for 7 days. The frequency with which at least one cell formed a sphere (37% mark on the y axis) was not
significantly different between p75+ and p75- cells. (E) Quantification of sphere formation in FACS-enriched p75+ and p75-
populations. Freshly sorted cells were plated onto six-well ultra-low-attachment plates at serial dilutions (5–100 · 103 cells/
well) and grown in media as described in Materials and Methods. The number of spheres was counted 1 week later and the
data presented are mean – SD of three independent experiments.
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their functional characteristics. Freshly isolated p75+ and
p75- cells were cultured on ultra-low attachment plates in
N2 medium containing EGF and bFGF. Twenty-four hours
after plating, cell clusters were found in both p75+ and p75-
cultures. These cells continued to proliferate and formed
spheres by 6–7 days. Antibody staining revealed that both
p75+ and p75- spheres expressed the neural stem cell
marker nestin, however, only spheres derived from p75+
cells were positive for neural crest markers p75, HNK1,
and AP2 (Fig. 4C). These data again indicate that FACS
sorting enriches for NCSCs in the p75+ cell fractions while
CNS stem cells, which also express nestin and possess
sphere-forming capability, remain predominantly in the
p75- fraction.
To further characterize these putative stem cells, we
performed clonal analysis of freshly isolated cells. Notably,
neither p75+ nor p75- cells could proliferate at clonal den-
sity in vitro immediately after isolation. Because we were
not able to generate colonies from freshly isolated single
cells, we performed a limiting dilution analysis [17]. In so
doing, we determined that the number of cells required to
generate at least one sphere/well was 432 cells/well in p75+
cells, and 420 cells/well in p75- cells (Fig. 4D). In addition,
we found that after 1 week, p75+ and p75- cells formed
spheres at similar efficiencies when cultured in the presence
of growth factors on ultra-low attachment plates (Fig. 4E).
Finally, mechanical dissociation and passaging of the
spheres revealed that both p75+ and p75- cells could be
maintained in these in vitro culture conditions for at least
three passages with continued expansion (data not shown).
Importantly, whereas differentiation of p75+ spheres re-
sulted in bias toward neural crest derivatives including
peripherin+ neurons and GFAP+/MBP+ Schwann cells (Fig.
5A and Supplementary Fig. 2), cultures derived from p75-
populations were enriched in MAP2+ CNS neurons and
GFAP+/MBP- astrocytes (Supplementary Fig. 2).
To address whether these hESC-derived putative NCSCs
could differentiate into multilineage neural crest derivatives
in vitro, multiple spheres were plated on poly-d-lysine/
fibronectin-coated plates for 2 weeks in the presence of
defined medium plus 5% FBS. As illustrated in Fig. 5A,
three major neural crest–derived cell types were detectable
after this differentiation period: peripherin+ neurons, glial fi-
brillary acidic protein (GFAP)+ glial cells and smooth muscle
actin (SMA)+ myofibroblasts. Clonal analysis of cells derived
from individual spheres (Fig. 5B) showed that in colonies
derived from p75+ cells, up to 28.6% showed differentia-
tion into cells from all three lineages including neurons,
FIG. 5. Human ESC–derived NCSCs give rise to multilineage neural crest derivatives. (A) p75+ spheres in bulk culture were
plated on poly-d-lysine- and fibronectin-coated coverslips in differentiation media for 2 weeks and then immunostained with
individual neural crest lineage markers separately (peripherin as peripheral neuronal marker; GFAP as glial marker; and SMA
as myofibroblastic marker). Three major neural crest–derived cell types were detectable after this differentiation period:
peripherin+ neurons, GFAP+ glial cells, and SMA+ myofibroblasts. (B) Single clonally derived spheres from FACS-sorted p75+
or p75- cells were handpicked and allowed to differentiate on poly-d-lysine- and fibronectin-coated coverslips in neural crest
differentiation media for 2 weeks and then assessed for evidence of tri-lineage differentiation using tri-labeling immunocy-
tochemistry. The left panel shows a representative example of a multipotent colony (3 lineages) generated from an individual
sphere. The histogram in the right panel demonstrates the quantification of different types of colonies generated from clonal
p75+ and p75- spheres. The frequencies of total colonies in each category are shown. Abbreviations: ESC, embryonic stem
cell; NCSC, neural crest stem cell; SMA, smooth muscle a-actin; NGM, multipotent colonies (positive staining for neurons,
glia, and myofibroblasts); NM, bipotent colonies with neurons and myofibroblasts; GM, bipotent colonies with glia and
myofibroblasts; NG, bipotent colonies with neurons and glia; G, unipotent glial colonies; M, unipotent myofibroblast colonies;
N, unipotent neuronal colonies; ND, no terminal neural crest differentiation detected.
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glial cells, and myofibroblasts, suggesting that these colonies
were derived from multipotent precursors. In addition, p75+
cells also generated colonies that comprised only two cell
types (i.e., 21.4% contained neurons and myofibroblasts,
7.1% contained myofibroblasts and glia, and 3.6% contained
neurons and glia) indicating the possibility that these cells
had derived from bipotent precursors. Finally, in 39.3% of
colonies derived from a single sphere only a single cell type
was identified, suggesting derivation from unipotent pre-
cursors. In contrast, although p75- cells formed spheres and
these spheres could be induced to differentiate, in nearly
half of the colonies no evidence of neural crest differenti-
ation was observed (Fig. 5B). While occasional colonies
with two cell types could be seen (15.3%), evidence of
terminal neural crest differentiation from p75- spheres was
primarily limited to cells of a single lineage (Fig. 5B). Thus,
FACS-based sorting of p75+ cells from differentiating
hESCs after 1 week of SDIA co-culture significantly en-
riches for putative NCSCs/NCPCs with multilineage dif-
ferentiation capacity.
Because peripherin is expressed by primary spinal mo-
toneurons as well as peripheral neurons, we examined
SDIA-induced cells for expression of the early motoneuron-
associated transcription factor HB9. As shown (Supple-
mentary Fig. 3), HB9 was not present in undifferentiated
hESCs, but was expressed after 1 week of co-culture. The
level of HB9 expression then declined dramatically by 3
weeks of co-culture, suggesting that motoneurons do not
persist in large numbers in PA6-differentiated cells. We also
examined the expression of a specific marker for cholinergic
neurons, ChAT in PA6-H9 co-culture. Again, expression of
ChAT was detected at 1 week of co-culture, but was unde-
tected in 3 week cultures. These results suggest that PA6
does not support the survival of spinal motoneurons or other
nondopaminergic neurons. In addition, we demonstrated
that neither HB9 nor ChAT transcript (Supplementary
Fig. 3) nor protein (immunostaining, data not shown) were
expressed by differentiated progeny derived from FACS-
sorted p75+ cells. Together these data support the conclu-
sion that peripherin staining cells are peripheral neurons and
not CNS-derived motoneurons.
To establish whether FACS-isolated hESC-derived, pu-
tative NCSCs are capable of self-renewal, we tested whether
individual cells derived from the primary spheres could
form secondary spheres. Primary spheres were dissociated
into single-cell suspensions and reseeded at clonal density in
cloning medium. In all cases, clonally derived spheres were
visible within 2 weeks. As shown in Table 1, p75+ cells
exhibited a higher subcloning efficiency than p75- cells
(11.6– 3.7% vs. 6.7 – 3.2%), indicating that although CNS
progenitors are likely to exist within the p75- population,
the p75+ neural crest fraction is more highly enriched for
self-renewing stem cells.
Finally, to address the issue of lineage specificity in
SDIA-induced hESCs we also examined the expression of
several mesoderm and endoderm differentiation markers in
PA6-hESCs co-cultures and FACS-isolated p75+ and p75-
populations. As shown (Supplementary Fig. 3), the meso-
derm marker Brachyury was induced early in co-culture but
disappeared by 3 weeks while GATA1 and MyoD were never
detected in differentiating, SDIA-induced H9 cells. Simi-
larly, the endodermal marker AFP was detected at early
timepoints only and PDX-1 was never induced. These results
confirm that terminal differentiation of hESCs into meso-
dermal and endodermal lineages is not supported by PA6
stromal cells without the addition of specific survival
factors. In addition, after FACS isolation, neither meso-
dermal nor endodermal markers were detectable in FACS-
Table 1. Self-Renewal Potential of Primary Neurospheres Generated From hESC-Derived p75+ and p75- Cells
p75– Mean – SD
Primary sphere
identity
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Cell numbers 476 310 250 582 530 380 350 568 360 390 280 168 246 250 420 240 210
Number of
secondary
spheres
35 30 27 13 25 56 44 37 48 30 32 14 6 6 8 22 4 8
Cloning
efficiency (%)
7.4 9.7 10.8 6.2 4.3 10.6 11.6 10.6 8.5 8.3 8.2 5.0 3.6 2.4 3.2 5.2 1.7 3.8 6.7 – 3.2
p75+ Mean – SD
Primary sphere
identity
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Cell numbers 560 385 202 310 270 250 108 150 346 258 220 105 120 264 120 246 380 278
Number of
secondary
spheres
68 47 17 55 30 32 12 15 44 30 22 18 6 18 24 30 36 24
Cloning
efficiency (%)
12.1 12.2 8.4 17.7 11.1 12.8 11.1 10.0 12.7 11.6 10.0 17.1 5.0 6.8 20.0 12.2 9.5 8.6 11.6 – 3.7a
Single cells dissociated from individual primary spheres inoculated in low attachment plates at clonal densities (10–30 cells/cm2). The
number of secondary spheres was counted 7–10 days later and cloning efficiency was calculated (% of total no. of seeded cells). Presented
data are compiled from two independent experiments.
aSignificant difference in secondary sphere formation between p75+ and p75- cells (P< 0.01, t-test).
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sorted cells (Supplementary Fig. 3) further supporting the
neuroectodermal lineage specificity of SDIA-induced, FACS-
sorted hESCs.
In vivo analysis of hESC-derived NCSCs
To determine whether hESC-derived NCSCs demonstrate
functionality in vivo we evaluated integration and migration
of these cells in the developing chick embryo. FACS-
purified hESC-derived NCSCs were transduced to express
GFP and grafted into the space adjacent to the midbrain of
H&H stage 10–12 chick embryos (Fig. 6A). Human NCSCs
were identified in embryo sections 3–5 days after cell in-
jection by the anti GFP antibody. Three days after trans-
plantation, we observed massive migration of hESC-derived
NCSC progeny to peripheral cranial neural crest target sites.
Many transplanted cells had migrated into the cranial mes-
enchyme (Fig. 6B) and trigeminal ganglion (Fig. 6C). In-
terestingly, some of the GFP+ cells in the cranial
mesenchyme were positive for SMA (Fig. 6C). Moreover,
we found that in the host trigeminal ganglion, some human
NCSCs had differentiated into HuC/HuD+ (Fig. 6E) and
Tuj1+ (Fig. 6F) neurons. Thus, these hESC-derived p75+
human cells demonstrate functional properties of NCSCs
in vivo in that they survive, migrate along neural crest mi-
gratory pathways, and differentiate into derivatives com-
patible with neural crest identity.
Discussion
The ability to generate terminally differentiated neural
crest cells from hESCs using SDIA co-culture has been
previously described [15]. However, we have found that the
efficiency of this process is inadequate for focused study of
neural crest as only 30% of differentiated colonies contain
peripherin+ peripheral nerves and many colonies show little
to no evidence of neural crest generation after 4 weeks. To
improve efficiency it has been recently shown that com-
bining SDIA co-culture with manual isolation of precursor
neurosphere colonies after 2 weeks can further increase the
yield of neural crest cells from hESCs [29,30]. In addition,
FACS-based enrichment of p75+ cells from differentiating
hESCs has been shown to be a viable means of NCSC
isolation, although this protocol is again both labor- and
time-intensive [21]. In this study, we have demonstrated that
the efficiency of neural crest differentiation can be dra-
matically improved by combining SDIA-co-culture with
FACS-based enrichment. Moreover, this protocol can be
used to successfully and efficiently isolate functional early
human NCSCs from hESCs.
Studies in a variety of animal models suggest that the
newly formed neural crest is comprised of cells that are
largely multipotent and that these cells become progres-
sively restricted with further development, though the
presence of some early restricted subpopulations cannot be
FIG. 6. Human embryonic stem cell–derived neural crest stem cells (NCSCs) give rise to NC derivatives in chick embryo.
(A) Freshly isolated p75+ cells were transduced with a GFP-lentivirus. Three days after transduction, cells were grafted into
the space between midbrain and hindbrain in H&H stage 10–12 chick embryos. White arrow shows location of the injection
site. (B and C) Three days after injections embryos were harvested and stained with GFP (Green). GFP+ cells migrated to
the cranial mesenchyme (B) and trigeminal ganglion (C). (D–F) Human NCSCs differentiate into neural crest derivatives in
chick embryo. (D) GFP+/SMA+ cells are detected in the cranial mesenchyme. (E) Two GFP+/Huc/HuD+ (pan early neuronal
marker) cells as indicated by the arrowhead are localized in the trigeminal ganglion. (F) GFP+/Tuj1+ cells in the trigeminal
ganglion. Scale bar= 100 mm.
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ruled out. Conversely, adult NCSC populations appear to
be retained in neural crest derivatives and other tissues,
like the epidermis (reviewed in ref. 1). Although progres-
sively restricted in their differentiation potential, these
cells maintain self-renewal potential at least through sev-
eral generations thereby earning them the stem cell des-
ignation [31,32]. Thus, the neural crest represents a
somewhat unique structure in which downstream progeny
cells maintain the stem cell property of self-renewal while
simultaneously undergoing fate restriction (reviewed in
ref. 33).
In our studies, we have used FACS to enrich for neural
crest cells that express p75. The ability to generate multiple
neural crest lineages from nearly 30% of clonally derived
p75+—spheres suggests that this FACS-based enrichment
successfully isolates early multipotent NCSCs. However, in
addition to tri-lineage (neural, glial, myofibroblast) differ-
entiation, dual- and single-lineage colonies were also de-
tected in abundance (32 and 39% of colonies, respectively).
Thus, it is likely that sorting on the basis of p75 alone
isolates not only multipotent NCSCs but also more restricted
bipotent and unipotent NCSCs. In particular, although
nearly all p75+ cells also expressed the early migratory
marker HNK1, small numbers of p75+/HNK1- cells were
present at the time of sorting and these cells may be rep-
resentative of post-migratory NCSCs. Alternatively, isolated
multipotent NCSCs may undergo progressive fate restriction
in vitro culture. In an attempt to address whether further
enrichment of p75+/HNK1+ cells would result in increased
generation of tri-lineage colonies we isolated dual positive
cells by FACS at day 6 of differentiation. Unfortunately, the
prolonged incubation and sorting times required for dual
staining resulted in a high degree of cell death that pre-
cluded quantitative analysis of differentiation capacity (data
not shown). Optimized studies using multiple markers and
lineage tracing are now required to fully address the issue of
fate restriction in these SDIA-induced, hESC-derived
NCSCs. In the meantime, we propose that this rapid ap-
proach using bulk sorting with a single antibody can be
reliably and reproducibly used to isolate large numbers of
human NCSCs/NCPCs for biologic study.
Importantly, we have confirmed that SDIA-induced,
hESC-derived NCSCs not only survive when transplanted
into the developing chick embryo, but also differentiate
into neural crest progeny including peripheral neurons and
smooth muscle in the cranial neural crest target sites. In-
terestingly, although glial differentiation was observed in
our in vitro studies we did not detect any human Schwann
cells in developing chick embryos 3 days after NCSC
transplantation. This result is in agreement with previous
studies which showed that hESC-derived NCSCs did not
differentiate into Schwann cells in either developing or
adult vertebrate hosts [21]. The lack of differentiation to-
ward glial fates in vivo in both studies may be due to the
fact that the generation of glial derivatives during periph-
eral nervous system development follows a stereotypic
sequence, with neurogenesis preceding gliogenesis and the
specification toward glial fates is a late event. Therefore,
optimized experiments using multiple time points and
different transplantation sites will be required to fully as-
sess the in vivo differentiation potential of hESC-derived
NCSCs.
Neural crest precursors with differentiation potential to-
ward melanocytes, neurons and GFAP+ cells have been
isolated from mouse embryonic stem cells using ST2 stro-
mal cells and cell sorting for c-KIT [34]. In contrast, PA6
co-cultured cells do not give rise to melanocytic derivatives
in the absence of cell sorting [14]. c-KIT is a marker pre-
viously used in the identification of embryonic stem cell–
derived melanocytes [35] and is considered as a marker of
committed migratory melanocyte precursors in vivo [36]. To
assess c-KIT status in differentiating hESCs, we used RT-
PCR to examine the expression of c-KIT in hESCs over the
course of SDIA exposure. c-KIT expression appeared as
early as day 1 of the culture, peaked at day 3 and remained
at high level until 3 weeks (data not shown). Thus, although
human NCSCs with melanocytic lineage potential may also
express c-KIT it will not be useful as a single marker for
NCSC enrichment protocols given its persistent expression
in terminally differentiated cultures. Whether combining
c-KIT with p75 and/or HNK-1 will permit selective isolation
of SDIA-induced human NCSCs that have maintained mel-
anocytic differentiation capacity remains to be determined.
Recently, the feasibility of generating NCSCs from
hESCs using an alternate protocol has also been reported
[21]. In these studies, NCSCs were successfully isolated
from hESC-derived neural rosettes. However, this rosette-
intermediate process requires nearly 4 weeks of directed
differentiation and is substantially more complex than the
simple 1-week protocol we describe herein. Given the dis-
parity in the two protocols, it is conceivable that the two
approaches yield cells that correspond to in vivo–derived
cells of different developmental stages. In particular, whe-
ther or not rosette-derived and SDIA-derived NCSCs pos-
sess equivalent differentiation and self-renewal capacities in
vitro and in vivo will be of great interest to determine and
direct comparison of these different techniques is now war-
ranted. In addition, comparison of rosette- or SDIA-derived
cells with adult tissue-derived NCSCs will provide insights
into the presumed ontogeny of hESC-derived neural crest cells.
There can be no doubt that knowledge of human neural
crest development will be profoundly enhanced by the
unique opportunities provided by in vitro–differentiated
hESCs. In addition, the ability to rapidly and reproducibly
generate large numbers of NCSCs for biologic study will be
invaluable for studies of disrupted neural crest development
as we endeavor to elucidate the pathogenesis of both benign
and malignant human neural crest disorders.
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